The latest genitourinary oncology news
Study finds link between colourblindness and death from bladder cancer
Recognising the sight of blood in urine, the most common first sign of bladder cancer,…
Browsing: GU Cancers
Targeting B-cells may boost immunotherapy in liver cancer treatment
Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy has transformed cancer treatment…
A simple urine test could revolutionise bladder cancer diagnosis and treatment
Researchers have discovered that analysing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple…
Gene silencing may slow down bladder cancer
Ladder cancer ranks among the ten most common types of cancer worldwide. The main treatment…
S3 E9 The Oncology Journal Club ESMO 2025 Special: Part 2
ESMO Special Part 2! Are you ready for ESMO Bingo? Welcome to Episode 9 of the third series of The Oncology Journal Club. Dr Kate Clarke takes over hosting duties as Professor Craig Underhill unpacks the GU and lung highlights. With witty commentary and a London Global Cancer Week sneak preview by Professor Christopher Jackson.
Molecular markers and risk models guide precision care in liver cancer surgery
Hyper-progression recurrence (HPR) after surgery for hepatocellular carcinoma (HCC) is a particularly aggressive relapse pattern…
Bout of cystitis may signal presence of urogenital cancers in middle-aged adults
A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which…
Understanding what makes some bladder cancers resistant to chemotherapy
About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive…
‘Fiery’ cell death during bladder cancer treatment may trigger chemotherapy resistance
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that…
Multifunctional nanoparticles for bimodal image-guided phototherapy in bladder cancer treatment
Bladder cancer remains a significant challenge in urology, with high recurrence rates and limited effective…